Table 6 |
||||
|
Relation between marker (E-Cadherin) and patient characteristics [182]. |
||||
|
E-Cadherin staining indexa |
||||
|
Low |
High |
|||
|
|
|
|||
|
Variable |
Number of patients |
% |
Number of patients |
% |
|
|
||||
|
Histologic type |
||||
|
Endometrioidb |
135 |
53 |
120 |
47 |
|
Clear-cell or serous papillary |
24 |
83 |
5 |
17 |
|
FIGO grade |
||||
|
1 |
25 |
49 |
26 |
51 |
|
2 |
63 |
51 |
61 |
49 |
|
3 |
71 |
65 |
38 |
35 |
|
Vascular invasion |
||||
|
0 or 1 vessel |
94 |
52 |
88 |
48 |
|
≥2 vessels |
65 |
64 |
37 |
36 |
|
Myometrial infiltrationc, % |
||||
|
<50 |
77 |
51 |
74 |
49 |
|
≥50 |
67 |
66 |
35 |
34 |
|
FIGO staged |
||||
|
I or II |
120 |
53 |
108 |
47 |
|
III or IV |
39 |
71 |
16 |
29 |
|
|
||||
|
aResults available in 284 patients; bAdenosquamous and adenoacanthoma are included; cInformation available in 253 patients (E-cadherin) and 255 patients (beta-catenin); dData missing in one patient. |
||||
|
Altman et al. BMC Medicine 2012 10:51 doi:10.1186/1741-7015-10-51 |
||||
